Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Caribou Biosciences, Inc. (CRBU) had Normalized Income after Taxes of $-24.28M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.50M |
|
$-24.28M |
|
-- |
|
$1.50M |
|
$26.84M |
|
$-25.34M |
|
$1.06M |
|
$-24.28M |
|
$-24.28M |
|
$-24.28M |
|
$-24.28M |
|
$-24.28M |
|
|
Normalized Income after Taxes |
$-24.28M |
$-25.34M |
|
$-24.76M |
|
100.99M |
|
100.99M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$116.59M |
|
$5.50M |
|
$26.18M |
|
$142.77M |
|
$17.97M |
|
-- |
|
$26.70M |
|
$44.67M |
|
$98.10M |
|
$98.10M |
|
$98.10M |
|
106.00M |
|
| Cash Flow Statement Financials | |
$-49.77M |
|
$42.93M |
|
$20.63M |
|
$12.41M |
|
$26.19M |
|
$13.79M |
|
$4.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1690.39% |
|
-1690.39% |
|
-- |
|
-1619.88% |
|
-1619.88% |
|
$35.74M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.12 |
|
80.33 |
|
-24.75% |
|
-24.75% |
|
-17.01% |
|
-24.75% |
|
$0.93 |
|
$0.35 |
|
$-0.49 |
|